Reader’s Digest – June 20
The problem? “The combination of these drugs with ibuprofen could significantly increase the risk for bleeding complications,” says David Craig, PharmD, pharmacist lead at the Moffitt Cancer Center and American Pain Society E-News editor.
Cancer Network – June 20
“In this cohort of patients in whom no effective systemic therapy was available, bridging radiation was able to safely bridge patients to [axicabtagene ciloleucel] therapy with outcomes after CAR T comparable to patients treated in recent clinical trials,” wrote Austin J. Sim, MD, JD, of Moffitt Cancer Center, and colleagues.
Everyday Health – June 20
A recent nationwide survey of oncologists by the NYU School of Medicine and the Moffitt Cancer Center, for example, found that nearly 83 percent of participants said they felt comfortable treating transgender patients, but only 37 percent said they were adequately trained to do so.
Business Observer – June 20
Using Immertec’s MedOptic platform, a doctor in Uganda, for example, could “scrub in” remotely and witness all aspects of an advanced surgical procedure at, say, Tampa’s Moffitt Cancer Center thanks to cameras set up in the operating theater that utilize the company’s proprietary, live-streaming 3D virtual reality software.
Fox 13 – June 19
In March, officials with the Moffitt Cancer Center testified and said in 90 days, robo calls took over 65 hours of response time. That is 65 hours they could have spent saving someone's life.
Digital Trends – June 19
According to Taylor Lehmann, chief information security officer of Tufts, his facility received more than 4,500 robocalls in just two hours on April 30, 2018. In a similar vein, the H. Lee Moffitt Cancer Center and Research Institute was rung more than 6,600 times across 90 days — a process that the center’s chief information security officer, Dave Summitt, estimates took up 65 hours of hospital response time.
The Today Show / NBC News – June 18
It’s uncommon for a patient to undergo chemotherapy for as long as Alvarez has, but it likely means the regimen continues to help keep the cancer under control, said Dr. Nikhil Khushalani, an oncologist at the Moffitt Cancer Center in Tampa, Florida. Khushalani is not treating Alvarez, but commented in general.
Fox News – June 18
Dave Summitt, chief information security officer for the H. Lee Moffitt Cancer Center and Research Institute, testified before Congress in March that robocalls are a "serious" threat to his company, with more than 6,600 robocalls having consumed 65 hours of hospital response time over the course of a 90-day period.
Naked Security – June 19
Dave Summitt, the CISO of one such besieged hospital, the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, testified in April 2019 in front of the House of Representatives about how overwhelmed healthcare organizations have become by the scourge.
OncLive – June 19
Rutika Mehta, MD, MPH, gastrointestinal medical oncologist, Moffitt Cancer Center, discusses the rationale and design of a phase II study of TAS-102 (trifluridine/tipiracil; Lonsurf) in combination with ramucirumab (Cyramza) in patients with advanced, refractory gastric or gastroesophageal junction (GEJ) adenocarcinoma (NCT03686488).
Becker’s Hospital Review – June 18
Some hospital IT leaders are heading to Congress to advocate for change. Dave Summit, CIO of H. Lee Moffitt Cancer Center and Research Institute, is among those leaders. At his Tampa-based medical center, he registered more than 6,600 robocalls over a 90-day period. Mr. Summit estimated that the robocalls consumed around 65 hours of hospital response time.
Z6 Magazine – June 18
Similarly, H. Lee Moffitt Cancer Center and Research Institute also received more than 6,600 times across 90 days — a process that the center’s chief information security officer, Dave Summitt, estimates took up 65 hours of hospital response time.
Washington Examiner – June 17
"These cancers are dormant or they hibernate and then they show up later, so you can almost use ‘cured' in quotation marks," said Dr. Eric Haura, chair of the Moffitt Cancer Center and Research Institute's thoracic oncology program. "The best we can say is, 'We see no evidence of your cancer,' but that’s not the same thing as being cured."
Washington Examiner – June 17
In an April hearing in front of the House Energy Committee, Dave Summitt, chief information security officer for the H. Lee Moffitt Cancer Center and Research Institute, elaborated on the threat that these calls provide to medical companies and hospitals, saying, "To amplify the extent of this problem, I am sharing data from our organizational phone system for the past 90 days.”
Washington Post – June 17
The continued threat to doctors and patients prompted Dave Summitt, chief information security officer for the H. Lee Moffitt Cancer Center and Research Institute, to take his concerns directly to Congress in March.
WTSP – June 17
Weaver didn’t have health insurance. Moffitt Cancer Center covered the cost of his cancer treatments until he was able to get insurance. “They are one of the best in the world,” Weaver said of Moffitt.
83 degrees – June 18
Following the passing of Amendment 2, the Florida Legislature in 2016 established the Medical Marijuana Research and Education (MMRE) board, which was to be funded by taxes levied against licensed medical marijuana growers in Florida, and operated through the Moffitt Cancer Center.
Computerworld – June 17
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, Fla.
AML Global Portal – June 17
At the 24th Congress of the European Hematology Association (EHA), David Sallman from the Moffitt Cancer Center, Tampa, US, discusses if the first-in-class anti-CD47 antibody HU5F9-G4 (5F9) could be a promising treatment strategy for patients with acute myeloid leukemia (AML).
Centre Daily Times – June 17
The 11 centers -which aren't required to justify their special treatment by the government, Bilimoria said - and their affiliated hospitals are the Dana Farber Cancer Institute (Boston); Brigham and Women's Hospital (Boston); Roswell Park Comprehensive Cancer Center (Buffalo, New York); Memorial Sloan-Kettering Cancer Center (New York City); Fox Chase Cancer Center (Philadelphia); University of Miami Hospital and Clinics-Sylvester Comprehensive Cancer Center (Miami, Florida; University of Miami Hospital; H. Lee Moffitt Cancer Center and Research Institute (Tampa, Florida); The Ohio State University James Cancer Hospital (Columbus); University of Texas MD Anderson Cancer Center (Houston); Seattle Cancer Care Alliance; University of Washington Medical Center (Seattle); USC Norris Comprehensive Cancer Hospital (Los Angeles); Keck Hospital of USC (Los Angeles); and City of Hope's Helford Clinical Research Hospital (Duarte, California).
Gizmodo – June 17
Dave Summitt, the chief information security officer at H. Lee Moffitt Cancer Center and Research Institute, recently told members of Congress that during one 90-day period his facility received 6,600 calls spoofing other Moffitt numbers, as well as 300 more mimicking Department of Justice numbers.
Business Wire – June 17
The summit will be chaired by Robert M. Wenham, M.D., M.S., FACOG, FACS, gynecologic oncologist and chair of the gynecologic oncology program at Moffitt Cancer Center.
PR Newswire – June 17
Currently, Upal is managing several multi-year, patient-focused research projects in Patient FoRCE, including Project ACTs, a study with University of Kentucky and Moffitt Cancer Center to identify barriers to adherence to lung cancer screening and developing shared-decision aids; Project Transform, a patient preference study with Johns Hopkins and Ohio State University; and Project PRIORITY, a study with the EGFR Resisters patient group to uncover the treatment experience of EGFR-positive lung cancer patients.
Ocala Star-Banner – June 16
Many people in Ocala do not realize a local not-for-profit organization, The Ocala Royal Dames for Cancer Research Inc., provided seed money to Dr. Shari Pilon-Thomas at Moffitt Cancer Center in Tampa for research.
OncLive – June 15
David Sallman, MD, Moffitt Cancer Center, explained the mechanism behind the combination treatment. “Azacitidine induces pro-phagocytic “eat me” signals on cancer cells, which acts synergistically with the CD47 blockade provided by the antibody overriding the “don’t eat me” signal and leading to enhanced phagocytosis.”
Gannett News – June 15
This year’s winners, besides StemRad and Lockheed Martin, were:
CadW Therapeutics, Moffitt Cancer Center of Tampa and SpacePharma of Israel … developing a microfluidics Lab-On-A-Chip that analyzes stress and DNA damage and responses during space flight.
AdventHealth – June 23
“We strive to provide world-class cancer care close to where people live and work,” said Alan F. List, MD, president and chief executive officer of Moffitt Cancer Center.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.